Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (198)	3/11/1998 12:03:00 PM
From: LJM	Read Replies (1) \| Respond to of 656

I purchased some IMNX yesterday on the news. I've just read through this thread and I am confused. Does Ligand have some sort of relationship with IMNX? If so, what is it? I've also been following Ligand for a little while, but have yet to make a purchase. I saw the IMNX interview this morning on CNBC and the size of the market for the Rheumatoid Arthritis drug sounded very promising. The pipeline looked strong, too, with an Asthma drug doing well in trials. I also know CNTO has a new drug Avakine which is close. (also for rheumatoid arthritis) Anyone know how the two drugs compare? LJM